Actively Recruiting
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
Led by University of California, Los Angeles · Updated on 2026-03-05
460
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether plain language summaries created by artificial intelligence can help adults better understand their eye doctor's notes. This study focuses on patients receiving eye care at the Jules Stein Eye Institute and aims to improve communication between patients and healthcare providers by making medical information clearer. The trial compares usual medical notes to notes supplemented with AI-generated summaries that explain complex eye care information in simple, everyday language. Participants are randomly assigned to one of two groups: one group receives the standard ophthalmology notes alone, while the other group receives these notes plus an AI-generated plain language summary reviewed by an ophthalmologist for accuracy. The AI system operates securely within UCLA's network and uses a customized large language model to generate clear explanations of medical details. No data is sent outside the secure environment, ensuring participant privacy. During the study, participants complete surveys immediately after their clinic visit to assess how well they understood their diagnosis, treatment, and follow-up plans. About one week later, they receive a follow-up phone call to further evaluate clarity and retention of information. Researchers also analyze patient comprehension scores and satisfaction, as well as time efficiency for ophthalmologists and other related outcomes. Data is securely stored and monitored throughout the trial, which is expected to last until June 2026.
CONDITIONS
Brief Title
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3e= 18 years
- English-speaking
- Receiving ophthalmology care at the Jules Stein Eye Institute
- Able to provide informed consent
You will not qualify if you...
- Known cognitive impairments (e.g., dementia, intellectual disability) that would affect comprehension
- Prisoners or wards of the state
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person during routine clinic visit)
Duration - 1 day
Participants receive either standard ophthalmology notes or standard notes plus an AI-generated plain language summary to help improve understanding of their diagnosis, treatment plan, and follow-up instructions. They complete surveys immediately after their clinic visit.
1 visit (in-person during clinic visit) plus survey completion immediately post-visit
Duration - Approximately 7 days after treatment
A follow-up telephone interview is conducted approximately 7 days after the clinic visit to assess retention and clarity of the information provided.
1 telephone interview
Trial Site Locations
Total: 1 location
1
UCLA
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
P
Prashant Tailor, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here